HK1205456A1 - 包含替格瑞洛的固態口服醫藥製劑 - Google Patents
包含替格瑞洛的固態口服醫藥製劑Info
- Publication number
- HK1205456A1 HK1205456A1 HK15106027.7A HK15106027A HK1205456A1 HK 1205456 A1 HK1205456 A1 HK 1205456A1 HK 15106027 A HK15106027 A HK 15106027A HK 1205456 A1 HK1205456 A1 HK 1205456A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical formulation
- formulation containing
- solid oral
- oral pharmaceutical
- containing ticagrelor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2012-705A CZ2012705A3 (cs) | 2012-10-16 | 2012-10-16 | Pevná orální farmaceutická formulace obsahující ticagrelor |
PCT/CZ2013/000130 WO2014059955A1 (en) | 2012-10-16 | 2013-10-15 | A solid oral pharmaceutical formulation containing ticagrelor |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1205456A1 true HK1205456A1 (zh) | 2015-12-18 |
Family
ID=49619770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15106027.7A HK1205456A1 (zh) | 2012-10-16 | 2015-06-24 | 包含替格瑞洛的固態口服醫藥製劑 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2908802A1 (zh) |
JP (1) | JP6301934B2 (zh) |
KR (1) | KR20150067153A (zh) |
CN (1) | CN104661649A (zh) |
BR (1) | BR112015008076A2 (zh) |
CZ (1) | CZ2012705A3 (zh) |
EA (1) | EA201590745A1 (zh) |
HK (1) | HK1205456A1 (zh) |
IL (1) | IL238036B (zh) |
MX (1) | MX2015003866A (zh) |
UA (1) | UA116784C2 (zh) |
WO (1) | WO2014059955A1 (zh) |
ZA (1) | ZA201501954B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160012706A (ko) * | 2014-07-25 | 2016-02-03 | 동아에스티 주식회사 | 서방성 제제 |
CN106074357B (zh) * | 2015-04-29 | 2021-07-02 | 江苏恒瑞医药股份有限公司 | 一种替格瑞洛或其可药用盐的制剂 |
CN105193759B (zh) * | 2015-09-18 | 2018-07-03 | 乐普药业股份有限公司 | 一种替格瑞洛片及其制备方法 |
CN106667926B (zh) * | 2015-11-09 | 2020-01-17 | 石药集团中奇制药技术(石家庄)有限公司 | 一种法匹拉韦片剂及其制备方法 |
TR201601835A2 (tr) * | 2016-02-12 | 2017-08-21 | Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi | Ti̇kagrelor i̇çeren formülasyonlar i̇çi̇n üreti̇m yöntemi̇ |
EA201892150A1 (ru) * | 2016-04-21 | 2019-05-31 | Астразенека Аб | Распадающиеся в полости рта таблетки |
TR201617983A2 (tr) * | 2016-12-07 | 2018-06-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Ti̇cagrelorun kati oral farmasöti̇k bi̇leşi̇mleri̇ |
KR102610876B1 (ko) * | 2018-03-05 | 2023-12-06 | 주식회사 파마코스텍 | 티카그렐러 푸마르산 i형 결정 및 그 제조방법 |
WO2019170244A1 (en) | 2018-03-08 | 2019-09-12 | Pharmaceutical Oriented Services Ltd. | Ticagrelor—containing tablet formulation |
WO2020021110A1 (en) | 2018-07-27 | 2020-01-30 | Krka, D.D., Novo Mesto | Pharmaceutical composition of ticagrelor |
CN111450067A (zh) * | 2019-01-18 | 2020-07-28 | 北京万全德众医药生物技术有限公司 | 一种替格瑞洛分散片及其制备方法 |
CN116370423A (zh) * | 2023-02-28 | 2023-07-04 | 天津力生制药股份有限公司 | 一种替格瑞洛口腔崩解片及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR017014A1 (es) | 1997-07-22 | 2001-08-22 | Astrazeneca Ab | Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos |
JPH11199517A (ja) * | 1997-10-31 | 1999-07-27 | Meiji Seika Kaisha Ltd | 口腔内速崩壊性錠剤 |
TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
GB0013407D0 (en) | 2000-06-02 | 2000-07-26 | Astrazeneca Ab | Forms of a chemical compound |
WO2007018057A1 (ja) * | 2005-08-05 | 2007-02-15 | Freund Corporation | 口腔内速崩壊錠およびその製造法 |
TWI482772B (zh) * | 2006-08-21 | 2015-05-01 | Astrazeneca Ab | 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物 |
WO2008024044A1 (en) * | 2006-08-21 | 2008-02-28 | Astrazeneca Ab | Compositions, suitable for oral administration, comprising a triazolo [4, 5] pyrimidin derivate |
CA2781182A1 (en) | 2009-12-03 | 2011-06-09 | Astrazeneca Ab | Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor |
EA026094B1 (ru) * | 2009-12-23 | 2017-03-31 | Рациофарм Гмбх | Твердая лекарственная форма тикагрелора |
-
2012
- 2012-10-16 CZ CZ2012-705A patent/CZ2012705A3/cs unknown
-
2013
- 2013-10-15 KR KR1020157007818A patent/KR20150067153A/ko not_active Application Discontinuation
- 2013-10-15 UA UAA201504754A patent/UA116784C2/uk unknown
- 2013-10-15 JP JP2015535983A patent/JP6301934B2/ja not_active Expired - Fee Related
- 2013-10-15 WO PCT/CZ2013/000130 patent/WO2014059955A1/en active Application Filing
- 2013-10-15 BR BR112015008076A patent/BR112015008076A2/pt not_active IP Right Cessation
- 2013-10-15 CN CN201380050404.5A patent/CN104661649A/zh active Pending
- 2013-10-15 MX MX2015003866A patent/MX2015003866A/es unknown
- 2013-10-15 EA EA201590745A patent/EA201590745A1/ru unknown
- 2013-10-15 EP EP13792574.9A patent/EP2908802A1/en not_active Withdrawn
-
2015
- 2015-03-20 ZA ZA2015/01954A patent/ZA201501954B/en unknown
- 2015-03-30 IL IL238036A patent/IL238036B/en not_active IP Right Cessation
- 2015-06-24 HK HK15106027.7A patent/HK1205456A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201501954B (en) | 2017-04-26 |
EP2908802A1 (en) | 2015-08-26 |
IL238036B (en) | 2019-05-30 |
WO2014059955A1 (en) | 2014-04-24 |
JP2015533129A (ja) | 2015-11-19 |
IL238036A0 (en) | 2015-05-31 |
JP6301934B2 (ja) | 2018-03-28 |
KR20150067153A (ko) | 2015-06-17 |
BR112015008076A2 (pt) | 2017-07-04 |
CZ2012705A3 (cs) | 2014-04-23 |
EA201590745A1 (ru) | 2015-08-31 |
UA116784C2 (uk) | 2018-05-10 |
CN104661649A (zh) | 2015-05-27 |
MX2015003866A (es) | 2015-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211209A1 (zh) | 含噻吩幷-三唑幷二氮雜化合物的藥物配方 | |
HK1205456A1 (zh) | 包含替格瑞洛的固態口服醫藥製劑 | |
EP2906202A4 (en) | DRUG FORMULATIONS FOR ORAL ADMINISTRATION | |
HRP20181193T1 (hr) | Farmaceutska kompozicija koja se može oralno administrirati | |
HK1199821A1 (zh) | 口服用醫藥組合物 | |
GB2486567B (en) | Pharmaceutical formulation | |
HK1205146A1 (zh) | 藥物製劑 | |
ZA201501897B (en) | A pharmaceutical composition | |
LT3473255T (lt) | Farmacinė vaisto forma, apimanti ciklezonidą | |
HK1207290A1 (zh) | 口服製劑 | |
PT2895171T (pt) | Uma formulação farmacêutica estável contendo cloridrato de vardenafila | |
LT2908836T (lt) | Farmacinė kompozicija, turinti kurkumino | |
HK1204945A1 (zh) | 含有氟吡汀的藥物製劑 | |
HK1209339A1 (zh) | 藥物配方 | |
GB201211406D0 (en) | Pharmaceutical formulations | |
GB201211403D0 (en) | Pharmaceutical formulations | |
GB201221367D0 (en) | A pharmaceutical composition |